Protea Biosciences Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GDPH135535D
Pages: 40
October 2018
Region : North America
GlobalData
Equity Research Report

Select a License

Single User License

USD 250

Site License

USD 500

Corporate User License

USD 750

Details
Table Of Content
Licence Rights
Section Purchase
Products and Companies

Details

Summary

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applications. Its products include functionalized pipette tips and plates, gel protein separation and recovery, protein sample preparation, amplus HPLC columns and mass spectrometry standards, among others. Protea's services include bioanalytical services and mass spec imaging services. The company's bioanalytical services include biomarker discovery, advanced proteomics and protein, biotherapeutic characterization and peptide quantitation, among others. It also provides label free imaging, translational, and drug and metabolite distribution. The company serves pharmaceutical, clinical, academic and industrial research. Protea is headquartered in Morgantown, West Virginia, the US.

Protea Biosciences Group Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Protea Biosciences Group Inc, Medical Devices Deals, 2012 to YTD 2018 10

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Protea Biosciences Enters into Co-Marketing Agreement with Proteos 12

Protea Biosciences Enters into Agreement with Agilent Technologies 13

Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 14

Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 15

Protea Biosciences Group Enters Into Co-Development Agreement With Oak Ridge National Lab 16

Licensing Agreements 17

Protea Biosciences Enters into License Agreement with George Washington University 17

Equity Offering 18

Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 18

Protea Biosciences Group Raises USD0.6 Million in Private Placement 19

Protea Biosciences Raises USD0.98 Million in Public Offering of Units 20

Protea Biosciences Raises USD2.53 Million in Public Offering of Units 21

Protea Biosciences Group Completes Private Placement Of Shares For USD 0.7 Million 22

Protea Biosciences Completes Private Placement Of Shares For USD 0.5 Million 23

Debt Offering 24

Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 24

Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 25

Protea Biosciences Raises USD2 Million in Private Placement of Debentures 26

Protea Biosciences Group Completes Private Placement Of Debt Securities For USD 0.3 Million 27

Asset Transactions 28

Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 28

Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 29

Acquisition 30

Protea Biosciences to Acquire vivoPharm for USD11.2 Million 30

AzurRx BioPharma Acquires ProteaBio Europe for USD7 Million 32

Protea Biosciences Group Inc-Key Competitors 34

Protea Biosciences Group Inc-Key Employees 35

Protea Biosciences Group Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Apr 18, 2017: Protea Announces 2016 Year End Results 37

Product News 38

Jun 21, 2017: Protea introduces new molecular imaging technology 38

Other Significant Developments 39

Jul 12, 2017: Protea Announces New Test Methods for Therapeutic Antibodies 39

Appendix 40

Methodology 40

About GlobalData 40

Disclaimer 40

List Of Figure

List of Figures

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Protea Biosciences Group Inc, Medical Devices Deals, 2012 to YTD 2018 10

List Of Table

List of Tables

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Key Facts 2

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Protea Biosciences Group Inc, Deals By Therapy Area, 2012 to YTD 2018 9